Open AccessJournal Article
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
1.7K
TL;DR: The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported, which should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents.
read more
Abstract: The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported The cultured cells show anchorage-independent growth in both monolayers and in soft agar suspension and produce subcutaneous tumors in nude mice Culture of the transplanted tumor yielded a human cell line with characteristics identical to those used initially to produce the tumor PC-3 has a greatly reduced dependence upon serum for growth when compared to normal prostatic epithelial cells and does not respond to androgens, glucocorticoids, or epidermal or fibroblast gowth factors Karyotypic analysis by quinacrine banding revealed the cells to be completely aneuploid with a modal chromosome number in the hypotriploid range At least 10 distinctive marker chromosomes were identified The overall karyotype as well as the marker chromosomes are distinct from those of the HeLa cell Electron microscopic studies revealed many features common to neoplastic cells of epithelial origin including numerous microvilli, junctional complexes, abnormal nuclei and nucleoli, abnormal mitochondria, annulate lamellae, and lipoidal bodies Overall, the functional and morphologic characteristics of PC-3 are those of a poorly-differentiated adenocarcinoma These cells should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays.
TL;DR: 22Rv1 cells seemed to be an appropriate model for the screening of androgenic endocrine disruptors, although it needs further studies with other steroid receptor and thyroid receptor.
39
Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cells.
Chien Jui Cheng,Xiang Cang Ye,Funda Vakar-Lopez,Jeri Kim,Shi Ming Tu,Dung Tsa Chen,Nora M. Navone,Li Yuan Yu-Lee,Sue Hwa Lin,Mickey C.T. Hu +9 more
TL;DR: It is suggested that the bone microenvironment and androgen status influence the subcellular localization of ErbB-3 in prostate cancer cells and may aid prostate cancer cell survival during androgen ablation and progression of prostate cancer in bone.
39
Interactions of a herbal combination that inhibits growth of prostate cancer cells.
TL;DR: The interaction between the most cytotoxic herbal component of a widely used herbal product and the other seven components was antagonistic, suggesting that herbal combinations can achieve synergism if combined properly.
39
Novel combination therapy against metastatic and androgen‐independent prostate cancer by using gefitinib, tamoxifen and etoposide
Murielle Mimeault,Ganesh Venkatraman,Sonny L. Johansson,Erik D. Moore,Jean-Pierre Hénichart,Patrick Depreux,Ming Fong Lin,Surinder K. Batra +7 more
TL;DR: The findings indicate that the combined use of inhibitors of EGF‐EGFR and E2‐ER‐β signaling with etoposide represents a promising strategy for a more effective treatment of metastatic PC forms.
39
Two bioactive mono-tetrahydrofuran acetogenins, annoglacins A and B, from Annona glabra
TL;DR: Two new bioactive mono-THF Annonaceous acetogenins, annoglacins A and B, have been isolated from the fractionated ethanolic extracts of the leaves of Annona glabra, directing the fractionation with the brine shrimp lethality test (BST).
39